Sign in
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2021
Comparative Survival of Patients with Posterior Uveal Melanoma Presenting Class 1A Versus Class 1B Gene Expression Profile
Zelia M. Correa, MD, PhD
Updates from the Field
2018
Incidence and features of uveal melanoma in a closed, managed care population
Michael Seider, MD
On Demand Cases, Courses, and Papers
2019
Category: Ocular Oncology